MISUMI Group (9962) · FactNo full-year amount recorded
Recording of an extraordinary loss for temporary expenses incurred due to COVID-19
First written in FY2022-Q3. . Latest entry: FY2024.
9entries
3years
0from disclosures
How it moved
Same theme, other companies
Extraordinary Losses for COVID-19 Infection-Prevention MeasuresA theme 5 companies write about · 5 as a headwind · 0 as a tailwind
2 other companies' latest entry also says "Other".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2024No full-year amount recordedAnnual report
「Not applicable.」
No loss attributable to COVID-19 was recorded as an extraordinary loss for the current consolidated fiscal year. - FY2024-Q3No entry recorded in the third quarterAnnual report
「Not applicable.」
No loss attributable to COVID-19 was recorded as an extraordinary loss during the cumulative third quarter of the current consolidated fiscal year. - FY2024-Q2No charge recorded for the current quarterAnnual report
「Not applicable.」
No loss attributable to COVID-19 was recorded as an extraordinary loss during the cumulative second quarter of the current consolidated fiscal year. - FY2024-Q1No charge recorded for the current quarterAnnual report
「Not applicable.」
The company did not recognize any losses arising from COVID-19 as an extraordinary loss during the first quarter of the current consolidated fiscal year. - FY2023Full-year amounts finalizedAnnual report
「Losses arising from COVID-19 90」
The company recognized ¥90 million in losses arising from COVID-19 as an extraordinary loss for the full fiscal year, including temporary expenses and other costs associated with preventing the spread of infection. - FY2023-Q2Update of the cumulative amount recognized through the second quarterAnnual report
「Losses arising from COVID-19 91」
The company recognized ¥91 million in losses arising from COVID-19 during the six months ended in the second quarter as temporary expenses and other costs associated with preventing the spread of infection. - FY2023-Q1Disclosure of the amount recognized in the first quarterAnnual report
「Losses arising from COVID-19 90」
Certain consolidated subsidiaries recognized ¥90 million in temporary expenses associated with preventing the spread of infection as an extraordinary loss in the first quarter. - FY2022Full-Year Amount ConfirmedAnnual report
「Losses arising from COVID-19 783」
The company recognized ¥783 million in losses arising from COVID-19 as an extraordinary loss for the full fiscal year, including temporary expenses associated with preventing the spread of infection. - FY2022-Q3First statedAnnual report
「Losses arising from COVID-19 703」
Certain consolidated subsidiaries recognized ¥703 million in temporary expenses associated with preventing the spread of infection as an extraordinary loss.